Co-Investors
Interested in co-investing?
Partner with Parkwalk
Parkwalk’s specialist focus and experienced team allow us to move quickly and deploy capital efficiently. We actively co-invest with other specialist funds and have built a trusted network of partners, co-investors and industry experts, giving us access to the highest-quality deal flow in UK university spinouts.
We invest from £250k to £10m per round, backing companies from early stage through to Series C and beyond. We look to follow our capital and support businesses over multiple rounds.
With over a decade of consistent performance, we’ve earned a reputation as a reliable, long-term partner. Parkwalk is the most co-invested fund in this asset class and deploys around £50m per year into the sector.
Transforming UK university research into global impact
Meet our companies
The companies we invest in are developing groundbreaking university research into successful businesses, spanning sectors including Life Sciences, AI, Quantum Computing, Advanced Materials, Genomics, CleanTech, Future of Mobility, MedTech and Big Data.
Mevitae
- Institution
- Oxford
Concr
- Institution
- Cambridge
MintNeuro
- Institution
- Imperial College
Where university innovation meets investor opportunity
Team
With over 160 years experience, the investment team is well versed in all things venture capital and M&A.
From lab to market
Investment Strategy
Parkwalk bridges the funding gap between early academic discovery and later-stage venture capital. We invest across the spinout lifecycle – from seed to scale – helping turn pioneering research into commercial success.
As part of IP Group plc, we back companies from start-up to scale-up, with a proven record of delivering consistent investor returns.